Northern Trust Corp Tonix Pharmaceuticals Holding Corp. Transaction History

Northern Trust Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.46 - $1.3 $23,693 - $66,959	51,507 Added 102.24%	101,887 $60,000
Q4 2022 Feb 13, 2023	SELL	$0.29 - $0.57 $0 - $1	-3 Reduced 0.01%	50,380 $19,000
Q3 2022 Nov 14, 2022	BUY	$0.53 - $1.9 $13,566 - $48,634	25,597 Added 103.27%	50,383 $27,000
Q2 2022 Aug 12, 2022	BUY	$1.58 - $7.36 $39,161 - $182,424	24,786 New	24,786 $39,000

Ticker TNXP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,752,700
Market Cap $7.81M
Description
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candid...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.